Prognostic Value of Angiogenesis and PAI-1 in Breast Cancer
Author Information
Author(s): Hansen S, Overgaard J, Rose C, Knoop Ann, Lænkholm A-V, Andersen J, Sørensen F B, Andreasen P A
Primary Institution: Odense University Hospital
Hypothesis
The study aims to evaluate the combined prognostic impact of angiogenesis and the levels of components of the plasminogen activator system in breast cancer patients.
Conclusion
Both PAI-1 and the Chalkley count provide significant and independent prognostic information on recurrence-free survival in patients with primary breast cancer.
Supporting Evidence
- High Chalkley counts were associated with increased risk of dying.
- PAI-1 levels above the median were linked to a 70% increased risk of recurrence.
- Chalkley count and PAI-1 provided independent prognostic information.
Takeaway
This study found that certain markers in breast cancer can help predict how well patients will do, which can help doctors make better treatment decisions.
Methodology
The study analyzed 228 patients with primary breast cancer, evaluating the association between Chalkley count, PAI-1, and uPA levels with classical prognostic factors.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the selection criteria for patient inclusion.
Limitations
The study is limited by the sample size and the specific patient population from a single institution.
Participant Demographics
The study included 228 patients with primary, unilateral, invasive breast carcinoma, with a median follow-up time of over 12 years.
Statistical Information
P-Value
p<0.0001 for overall survival related to Chalkley count
Confidence Interval
95% CI for PAI-1 and Chalkley count risk estimates
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website